Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of AZD2171 and WBRT in Patients With Brain Metastases

NCT00937482 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00937482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00937482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of AZD2171 and WBRT in Patients With Brain Metastases
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Terminated
Start date
August 31, 2009
Completion date
Not reported
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

male breast cancer, stage iv breast cancer, stage iv melanoma, stage iv non-small cell lung cancer, stage iv renal cell cancer, stage iva colon cancer, stage iva rectal cancer, stage ivb colon cancer, stage ivb rectal cancer, tumors metastatic to brain